Detailed information for compound 300356

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 308.338 | Formula: C16H16N6O
  • H donors: 1 H acceptors: 4 LogP: 1.13 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: Nc1ncnc2c1ccc(n2)c1ccc(nc1)N1CCOCC1
  • InChi: 1S/C16H16N6O/c17-15-12-2-3-13(21-16(12)20-10-19-15)11-1-4-14(18-9-11)22-5-7-23-8-6-22/h1-4,9-10H,5-8H2,(H2,17,19,20,21)
  • InChiKey: ITUXIIYRXPLYNH-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Adenosine kinase Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Candida albicans adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma brucei gambiense adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma cruzi adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Babesia bovis adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Leishmania major adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Toxoplasma gondii kinase, pfkB family protein Get druggable targets OG5_128398 All targets in OG5_128398
Brugia malayi Adenosine kinase-like Get druggable targets OG5_128398 All targets in OG5_128398
Leishmania mexicana adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Echinococcus granulosus adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Cryptosporidium parvum adenosine kinase like ribokinase Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma brucei gambiense adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Schistosoma japonicum ko:K00856 adenosine kinase [EC2.7.1.20], putative Get druggable targets OG5_128398 All targets in OG5_128398
Neospora caninum GG10762, related Get druggable targets OG5_128398 All targets in OG5_128398
Leishmania donovani adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Schistosoma mansoni adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Leishmania infantum adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma congolense adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Schistosoma mansoni adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma brucei adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma brucei adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Echinococcus multilocularis adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Leishmania braziliensis adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma cruzi adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Candida albicans putative adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Onchocerca volvulus Get druggable targets OG5_128398 All targets in OG5_128398

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Leishmania infantum adenosine kinase-like protein Adenosine kinase   361 aa 351 aa 37.6 %
Leishmania braziliensis adenosine kinase-like protein Adenosine kinase   361 aa 351 aa 37.6 %
Leishmania donovani adenosine kinase-like protein Adenosine kinase   361 aa 351 aa 37.6 %
Candida albicans similar to Ribokinase Adenosine kinase   361 aa 303 aa 21.5 %
Leishmania mexicana adenosine kinase-like protein Adenosine kinase   361 aa 344 aa 36.6 %
Candida albicans similar to Ribokinase Adenosine kinase   361 aa 309 aa 20.7 %
Schistosoma mansoni ribokinase Adenosine kinase   361 aa 289 aa 23.2 %
Leishmania major adenosine kinase-like protein Adenosine kinase   361 aa 351 aa 36.8 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma brucei adenosine kinase, putative 0.0105 1 0.5
Schistosoma mansoni adenosine kinase 0.0105 1 0.5
Echinococcus multilocularis adenosine kinase 0.0105 1 0.5
Onchocerca volvulus 0.0093 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0105 1 0.5
Trypanosoma brucei adenosine kinase, putative 0.0105 1 0.5
Toxoplasma gondii kinase, pfkB family protein 0.0105 1 0.5
Schistosoma mansoni adenosine kinase 0.0105 1 0.5
Trypanosoma cruzi adenosine kinase, putative 0.0105 1 0.5
Trypanosoma cruzi adenosine kinase, putative 0.0105 1 0.5
Leishmania major adenosine kinase, putative 0.0105 1 0.5
Echinococcus granulosus adenosine kinase 0.0105 1 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 562 nM Inhibitory activity against cytosolic adenosine kinase by ADO phosphorylation assay ChEMBL. 11140740
IC50 (binding) = 562 nM Inhibitory activity against cytosolic adenosine kinase by ADO phosphorylation assay ChEMBL. 11140740
IC50 (binding) > 1000 nM Inhibitory activity against intact cell adenosine kinase by ADO phosphorylation assay ChEMBL. 11140740
IC50 (binding) > 1000 nM Inhibitory activity against intact cell adenosine kinase by ADO phosphorylation assay ChEMBL. 11140740

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.